… Temporal trends for surgical management of low risk papillary thyroid cancers. The …
controversial, and this study suggests that CESQIP surgeons have not fully embraced TL for low-risk …

… Furthermore, TSH suppressive therapy is widely accepted as a treatment intended for the
prevention of metastatic recurrence after thyroid cancer surgery. Controversial data regarding …

… thyroid cancer also acknowledged a policy of active surveillance for low-risk PTMCs [4]. …
veillance group was found to experience fewer problems involving the nerves, muscles, pharynx…

… to low-risk papillary thyroid cancer over a … for lowrisk papillary thyroid microcarcinomas at
Kuma Hospital: gradual increase and heterogeneity in the acceptance of this new management …

… For patients at low risk for persistent or recurrent disease, the … (RAI Tx) after thyroidectomy
has long been controversial (8, 9)… the treatment strategy used for PTC in our thyroid cancer unit…

… There have been several meta-analyses on recurrence risk and specific mortality in low-risk
thyroid cancer, all reporting better outcome with TT (possibly completed by RAI) than LI. The …

… therapy (RIT) for intermediate-risk or high-risk differentiated thyroid cancer (DTC) patients
is controversial. … T1aN0M0 and T1bN0M0 PTCs are classified as very low risk and low risk, …

… low-risk thyroid cancer, it requires careful patient selection, effective communication for
shared decision-making, standardized follow-up protocols, and a clear definition of disease …

… They concluded that there was no benefit of TSH suppression therapy in low-risk patients […
recurrence for low-risk patients of differentiated thyroid cancer. There is still controversy about …

… This review discusses treatment options for low-risk thyroid cancer focusing on options
that are less intensive while exploring the benefits and limitations of each treatment. “Low-risk” …